« previous next »
Pages: [1]

Author Topic: MS patient on Gilenya with severe COVID-19 reported  (Read 52 times)

0 Members and 0 Guests are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 9549
  • MS diagnosed 1980
  • Location: Pacific Northwest
MS patient on Gilenya with severe COVID-19 reported
« on: May 18, 2020, 04:38:30 pm »
This abstract from PubMed (May 18, 2020) describes a patient with MS on fingolimod who had severe COVID-19 but was apparently treated successfully with tocilizumab:


https://msspeaks.createaforum.com/general-discussion/(abst-)-covid-19-and-ms-disease-modifying-therapies/
« Last Edit: April 25, 2022, 07:01:25 am by agate »
Report to moderator   Logged
MS Speaks--online for 17 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) since 12/16/20.
Pages: [1]
« previous next »
 

Related Topics

  Subject / Started by Replies Last post
0 Replies
132 Views 		Last post March 09, 2017, 06:58:58 am
by agate
2 Replies
196 Views 		Last post December 26, 2018, 11:46:15 am
by agate
0 Replies
99 Views 		Last post December 17, 2018, 10:02:37 am
by agate
6 Replies
173 Views 		Last post March 25, 2019, 10:13:43 am
by agate
0 Replies
46 Views 		Last post May 15, 2020, 12:36:31 pm
by agate